Skip to main content

Dendritic Cell-based Immune Therapy: Concept, Design, Present Limitations, and Future Projections

  • Chapter
Dendritic Cells in Clinics
  • 348 Accesses

Abstract

Immune therapy seems to be a rational therapeutic choice for treating patients with immune-mediated anomalies. In some diseases, immune-related factors are primarily responsible for disease pathogenesis. Autoimmune diseases are a typical example. In addition, an immune-mediated phenomenon is related to rejection of organ transplants. Thus, immune therapy may be used for treating autoimmune diseases. Rejection of transplanted organs may be delayed or blocked by immune intervention strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Recommended Readings

  • Banchereau J, Palucka AK (2005) Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5:296–306

    Article  CAS  PubMed  Google Scholar 

  • Fazle Akbar SM, Abe M, Yoshida O, Murakami H, Onji M (2006) Dendritic cell-based therapy as a multidisciplinary approach to cancer treatment: present limitations and future scopes. Curr Med Chem 13:3113–3119

    Article  CAS  PubMed  Google Scholar 

  • Figdor CG, De Vries IJ, Lesterhuis WJ, Melief CJ (2006) Dendritic cell immunotherapy: mapping the way. Nat Med 10:475–480

    Article  CAS  Google Scholar 

  • Mocellin S (2005) Cancer vaccines: the challenge of developing an ideal tumor killing system. Front Biosci 10:2285–2305

    Article  CAS  PubMed  Google Scholar 

  • Slingluff CL Jr, Engelhard VH, Ferrone S (2006) Peptide and dendritic cell vaccines. Clin Cancer Res 12:2342s–2345s

    Article  CAS  PubMed  Google Scholar 

  • Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature (Lond) 449:419–426

    Article  CAS  Google Scholar 

  • Tuyaerts S, Aerts JL, Corthals J, Neyns B, Heirman C, Breckpot K, Thielemans K, Bonehill A (2007) Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunol Immunother 56:1513–1537

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Morikazu Onji and Sk. Md. Fazle Akbar

About this chapter

Cite this chapter

(2008). Dendritic Cell-based Immune Therapy: Concept, Design, Present Limitations, and Future Projections. In: Dendritic Cells in Clinics. Springer, Tokyo. https://doi.org/10.1007/978-4-431-79466-0_8

Download citation

Publish with us

Policies and ethics